unmet needs in the treatment of t-cell malignancies
Published 2 years ago • 42 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:15
key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
-
1:08
unmet needs in t-all: targeted therapies & managing relapse
-
1:13
the unmet needs and future of cmml treatment
-
2:43
t-cell engaging treatment in aml
-
2:29
unmet clinical needs in bpdcn: improving diagnosis and treatment approaches
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
3:30
unmet needs in mf: managing anemia & improving the efficacy of first and second-line treatments
-
35:50
t-cell memory and exhaustion
-
2:09
human’s hematology testimonial video
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
1:24
unmet needs in ttp
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
3:11
unmet needs in bpdcn and strategies to optimize care for patients
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
1:49
pid unmet needs: awareness, testing and diagnosis
-
1:58
unmet needs in sr-agvhd and tr-agvhd
-
3:49
the patient burden of illness and unmet needs in scd & highlights from eha 2024